Abstract
Enzyme inhibitors are important tools of nature for regulating the activity of enzymes in case of emergency. Proteinaceous inhibitors are the best studied in this group. Comparatively less is known about the inhibitors of α-amylase, which might be an attractive candidate having potentials in various fields, from the treatment of diabetes to crop protection. The area has benefited from the recent determination of structures of α-amylases, inhibitors and complexes. Besides, discussing various types of α-amylase inhibitors and their structural basis of inhibition, the biotechnological approaches for exploitation of its inhibitory function have been outlined in this minireview.
Keywords: Amylase, inhibitor, acarbose, starch, diabetes, Proteinaceous inhibitors, α-amylase, phytopathogenic microorganisms, transgenic plants, Eleusine coracana, porcine pancreas (PPA), Streptomyces, Sorghum, Trichoderma resei, 3-D structure, hyperglycemia, acarviosine-glucose, α-amylase inhibitor, Apostolidis, γ-purothionin, thaumatin, Tribolium castaneum, bruchids, pig pancreatic α-amylase, Ragi bifunctional inhibitor, sorghum inhibitor, Ragi α-amylase/trypsin inhibitor, Barley α-amylase/subtilisin inhibitor
Current Enzyme Inhibition
Title: α-Amylase Inhibition: Some Practical Considerations
Volume: 6 Issue: 3
Author(s): Om Prakash and Nivedita Jaiswal
Affiliation:
Keywords: Amylase, inhibitor, acarbose, starch, diabetes, Proteinaceous inhibitors, α-amylase, phytopathogenic microorganisms, transgenic plants, Eleusine coracana, porcine pancreas (PPA), Streptomyces, Sorghum, Trichoderma resei, 3-D structure, hyperglycemia, acarviosine-glucose, α-amylase inhibitor, Apostolidis, γ-purothionin, thaumatin, Tribolium castaneum, bruchids, pig pancreatic α-amylase, Ragi bifunctional inhibitor, sorghum inhibitor, Ragi α-amylase/trypsin inhibitor, Barley α-amylase/subtilisin inhibitor
Abstract: Enzyme inhibitors are important tools of nature for regulating the activity of enzymes in case of emergency. Proteinaceous inhibitors are the best studied in this group. Comparatively less is known about the inhibitors of α-amylase, which might be an attractive candidate having potentials in various fields, from the treatment of diabetes to crop protection. The area has benefited from the recent determination of structures of α-amylases, inhibitors and complexes. Besides, discussing various types of α-amylase inhibitors and their structural basis of inhibition, the biotechnological approaches for exploitation of its inhibitory function have been outlined in this minireview.
Export Options
About this article
Cite this article as:
Prakash Om and Jaiswal Nivedita, α-Amylase Inhibition: Some Practical Considerations, Current Enzyme Inhibition 2010; 6 (3) . https://dx.doi.org/10.2174/157340810793384089
DOI https://dx.doi.org/10.2174/157340810793384089 |
Print ISSN 1573-4080 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6662 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Hypovitaminosis D is Associated with Endothelial Dysfunction in Patients with Metabolic Syndrome
Current Vascular Pharmacology Novel Approaches to Target Pancreatic Cancer
Current Cancer Drug Targets Benefits of L-Arginine on Cardiovascular System
Mini-Reviews in Medicinal Chemistry Atypical Presentation Of Anti-Retroviral Therapy Induced Lactic Acidosis as Acute Right Ventricular Failure And Severe Pulmonary Hypertension
New Emirates Medical Journal Editorial (Thematic Issue: Managing Strategies for Diverse Diseases: Challenges from Bench to Bedside Translation in Successful Drug Discovery and Development (Part B))
Current Pharmaceutical Design Human postnatal Mesenchymal Stem Cell Derived Islets as a Model for Diabetes Research
Current Diabetes Reviews Current Treatment Strategies for Non-Alcoholic Fatty Liver Disease (NAFLD)
Current Drug Discovery Technologies Nutrition Communication in General Practice
Current Nutrition & Food Science Poly-Pharmacy Among the Elderly: Analyzing the Co-Morbidity of Hypertension and Diabetes
Current Pharmaceutical Design Cardiorenal Consequences of Atherosclerosis and Statins Therapy: From the Past to the Future
Current Pharmaceutical Design Stem Cells Derived from Human Exfoliated Deciduous Teeth (SHED) in Neuronal Disorders: A Review
Current Stem Cell Research & Therapy Diabetes and Chronic Heart Failure: From Diabetic Cardiomyopathy to Therapeutic Approach
Endocrine, Metabolic & Immune Disorders - Drug Targets Role of NUCB2/nesfatin-1 in Glucose Control: Diverse Functions in Islets, Adipocytes and Brain
Current Pharmaceutical Design Synthesis and Investigation on the Antidiabetic Effect of 3-aryl-1-(5-methylisoxazol-3-ylamino)-1-(4-nitrophenyl) Propan-1-one
Letters in Drug Design & Discovery Evidence for a Putative Relationship Between Type 2 Diabetes and Neoplasia with Particular Reference to Breast Cancer: Role of Hormones, Growth Factors and Specific Receptors
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Subject Index To Volume 3
Vascular Disease Prevention (Discontinued) Hypertension, Prehypertension and Blood Pressure Related Diseases
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Beta-blockers in the Perioperative Period: Are there Indications other than Prevention of Cardiac Ischemia?
Current Drug Targets Niacin: From Mechanisms of Action to Therapeutic Uses
Mini-Reviews in Medicinal Chemistry Micro-RNAs, Exercise and Cellular Plasticity in Humans: The Impact of Dietary Factors and Hypoxia
MicroRNA